Get started
Author

Karina-Doris Vihta

Observed names: Karina Doris Vihta, Karina Doris Vihta1, Karina Doris-Vihta, Karina Vihta, Vihta, Karina-Doris
Observed institutions: John Radcliffe Hospital, National Institute for Health and Care Research, University of Warwick, University of Oxford, London School of Hygiene & Tropical Medicine, Institutul Clinic Fundeni, UK Health Security Agency
ORCID: 0000-0002-4111-7577
Observed ORCID: 0000-0002-4111-7577
OpenAlex ID: A5029319019
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
2021 · Koen B. Pouwels, Emma Pritchard, et al. · Nature Medicine · 526
PDF
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom
2021 · Jia Wei, Nicole Stoesser, et al. · Nature Microbiology · 331
PDF
Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom
2021 · Emma Pritchard, Philippa C. Matthews, et al. · Nature Medicine · 322
PDF
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
2022 · Jia Wei, Koen B. Pouwels, et al. · Nature Medicine · 248
PDF
Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey
2020 · Koen B Pouwels, Thomas House, et al. · The Lancet Public Health · 172
PDF
Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998–2016: a study of electronic health records
2018 · Karina-Doris Vihta, Nicole Stoesser, et al. · The Lancet Infectious Diseases · 161
PDF
Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
2021 · Jia Wei, Philippa C. Matthews, et al. · Nature Communications · 136
PDF
Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time
2021 · A. Sarah Walker, Emma Pritchard, et al. · eLife · 132
Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom
2022 · Karina Doris Vihta1, Koen B Pouwels, et al. · Clinical Infectious Diseases · 127
PDF
Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom
2021 · A. Sarah Walker, Karina-Doris Vihta, et al. · New England Journal of Medicine · 82
Ten-year longitudinal molecular epidemiology study of Escherichia coli and Klebsiella species bloodstream infections in Oxfordshire, UK
2021 · Samuel Lipworth, Karina-Doris Vihta, et al. · Genome Medicine · 78
PDF
Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population
2024 · Jia Wei, Nicole Stoesser, et al. · Nature Communications · 73
PDF
High Rates of Human Fecal Carriage of mcr-1–Positive Multidrug-Resistant Enterobacteriaceae Emerge in China in Association With Successful Plasmid Families
2017 · Lan-Lan Zhong, Hang TT Phan, et al. · Clinical Infectious Diseases · 69
PDF
Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom
2021 · Karina Doris Vihta, Koen B Pouwels, et al. · Clinical Infectious Diseases · 57
Increased infections, but not viral burden, with a new SARS-CoV-2 variant
2021 · A. Sarah Walker, Karina-Doris Vihta, et al. · medRxiv · 57
PDF
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK
2023 · Jia Wei, Philippa C. Matthews, et al. · Nature Communications · 46
PDF
The plasmidome associated with Gram-negative bloodstream infections: A large-scale observational study using complete plasmid assemblies
2024 · Samuel Lipworth, William Matlock, et al. · Nature Communications · 36
PDF
Ten Years of Population-Level Genomic Escherichia coli and Klebsiella pneumoniae Serotype Surveillance Informs Vaccine Development for Invasive Infections
2021 · Samuel Lipworth, Karina-Doris Vihta, et al. · Clinical Infectious Diseases · 33
PDF
SARS-CoV-2, influenza A/B and respiratory syncytial virus positivity and association with influenza-like illness and self-reported symptoms, over the 2022/23 winter season in the UK: a longitudinal surveillance cohort
2024 · Elisabeth Dietz, Emma Pritchard, et al. · BMC Medicine · 25
PDF
Monitoring populations at increased risk for SARS-CoV-2 infection in the community using population-level demographic and behavioural surveillance
2021 · Emma Pritchard, Joel Jones, et al. · The Lancet Regional Health - Europe · 24
PDF
Predicting future hospital antimicrobial resistance prevalence using machine learning
2024 · Karina-Doris Vihta, Emma Pritchard, et al. · Communications Medicine · 23
PDF
SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection
2022 · Jia Wei, Philippa C. Matthews, et al. · Nature Communications · 22
PDF
COVID-19 vaccination, risk-compensatory behaviours, and contacts in the UK
2023 · John Buckell, Joel Jones, et al. · Scientific Reports · 20
PDF
Molecular epidemiology and antimicrobial resistance phenotype of paediatric bloodstream infections caused by Gram-negative bacteria
2022 · Sam Lipworth, Karina-Doris Vihta, et al. · Communications Medicine · 19
PDF
Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification
2024 · Koen B. Pouwels, David W. Eyre, et al. · Nature Communications · 12
Works count: 41
Citation count: 3,103
H-index: 23
I10-index: 28
Year
Topic
Type